Table 4.
Consensus (direction) |
Very important (6–7) n (%) |
Moderately important (5) n (%) |
Neutral (4) N (%) |
Less important (3) n (%) |
Not important (1–2) n (%) |
|
---|---|---|---|---|---|---|
Management of advanced symptoms | High (VI) | 45 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Access to care | High (VI) | 45 (100.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Palliative care | High (VI) | 44 (97.8) | 1 (2.2) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Multidisciplinary teams | High (VI) | 43 (95.6) | 2 (4.4) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Managing physical effects | High (VI) | 43 (95.6) | 1 (2.2) | 1 (2.2) | 0 (0.0) | 0 (0.0) |
Psychosocial care | High (VI) | 42 (93.3) | 3 (6.7) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Up‐to‐date information | High (VI) | 42 (93.3) | 3 (6.7) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Surveillance of recurrence and second cancers | High (VI) | 42 (93.3) | 2 (4.4) | 1 (2.2) | 0 (0.0) | 0 (0.0) |
Care coordination | High (VI) | 42 (93.3) | 3 (6.7) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Shared and informed decision | High (VI) | 41 (91.1) | 3 (6.7) | 1 (2.2) | 0 (0.0) | 0 (0.0) |
Person‐centred care | High (VI) | 41 (91.1) | 3 (6.7) | 1 (2.2) | 0 (0.0) | 0 (0.0) |
Family support for the patient | High (VI) | 41 (91.1) | 3 (6.7) | 1 (2.2) | 0 (0.0) | 0 (0.0) |
Prostate cancer specialist nurses | High (VI) | 40 (88.9) | 5 (11.1) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Monitoring physical effects | High (VI) | 39 (86.7) | 4 (8.9) | 2 (4.4) | 0 (0.0) | 0 (0.0) |
Exercise, physical activity and nutrition | High (VI) | 39 (86.7) | 5 (11.1) | 1 (2.2) | 0 (0.0) | 0 (0.0) |
Health promotion | High (VI) | 39 (86.7) | 3 (6.7) | 1 (2.2) | 1 (2.2) | 1 (2.2) |
Screening for psychosocial effects | High (VI) | 39 (86.7) | 5 (11.1) | 1 (2.2) | 0 (0.0) | 0 (0.0) |
Self‐management | High (VI) | 39 (86.7) | 4 (8.9) | 1 (2.2) | 1 (2.2) | 0 (0.0) |
Management of comorbidities | High (VI) | 38 (84.4) | 5 (11.1) | 1 (2.2) | 0 (0.0) | 1 (2.2) |
Maintaining intimate relationships | High (VI) | 38 (84.4) | 7 (15.6) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Advocacy | High (VI) | 37 (82.2) | 3 (6.7) | 3 (6.7) | 2 (4.4) | 0 (0.0) |
Surveillance of comorbidities | High (VI) | 37 (82.2) | 7 (15.6) | 0 (0.0) | 1 (2.2) | 0 (0.0) |
Empowerment | High (VI‐MI) | 35 (77.8) | 8 (17.8) | 1 (2.2) | 1 (2.2) | 0 (0.0) |
Psychosocial care of family members | High (VI‐MI) | 30 (66.7) | 13 (28.9) | 2 (4.4) | 0 (0.0) | 0 (0.0) |
Financial assistance | High (VI‐MI) | 28 (62.2) | 9 (20.0) | 6 (13.3) | 2 (4.4) | 0 (0.0) |
Peer support | High (VI‐MI) | 27 (60.0) | 12 (26.7) | 6 (13.3) | 0 (0.0) | 0 (0.0) |
MI, moderately important; VI, very important.